First Xarelto Bellwether Results in Victory for Bayer/J&J
Last week, the first bellwether trial over Xarelto, a “new generation” blood thinner jointly developed by Bayer and Johnson & Johnson, concluded. The jury found in favor of the Big Pharma defendants on Wednesday, after less than three hours of deliberation. Bellwether trials are a means for parties and attorneys to test their arguments and










